Radiation therapy may be safely omitted for patients with primary mediastinal B-cell lymphoma (PMBCL) who achieved a complete metabolic response after immunochemotherapy.
Androgen deprivation therapy (ADT) given for 24 months in the postoperative setting, combined with radiotherapy, was superior to 6 months of administration for improving metastasis-free survival.